Drugs / CAR-T(CD70)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07113977 | Aug 2025 → Aug 2028 expected | renal cell carcinoma | Wei Guan | Not yet recruiting | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAR-T(CD70) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07113977 ↗ |
| Modality | Cell therapy | “novel humanized CD70-targeted CAR-T-cell product” NCT07113977 ↗ |
| Route | Other | “administered intratumorally under CT guidance” NCT07113977 ↗ |
| Target | CD70 | “CD70-targeted” NCT07113977 ↗ |